fbpx

ABOUT VHIO

VHIO is a leading comprehensive cancer center of excellence where its scientists and physicians adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer:

DISCOVER MORE

PROGRAMS & GROUPS

Scientific activity at VHIO is structured across for major programs: Preclinical, Translational, Clinical Research, and Core Technologies. Each incorporates research teams of excellence dedicated to harnessing and rapidly translating discoveries into tangible benefits for patients.

MEET VHIO´S TEAMS

NEWS

World Cancer Day 2021: saluting the strength of the cancer community through the COVID-19 pandemic

26/01/2021|Comments Off on World Cancer Day 2021: saluting the strength of the cancer community through the COVID-19 pandemic

The passing of a true giant and trailblazer in oncology: Prof. Gordon McVie 1945-2021

22/01/2021|Comments Off on The passing of a true giant and trailblazer in oncology: Prof. Gordon McVie 1945-2021

Not to be missed: ESMO’s virtual and expert Live Roundtable on COVID-19 vaccination in cancer patients, this Friday 22 January

21/01/2021|Comments Off on Not to be missed: ESMO’s virtual and expert Live Roundtable on COVID-19 vaccination in cancer patients, this Friday 22 January

VHIO to incorporate Guardant Health’s breakthrough liquid biopsy technology in 2021

18/01/2021|Comments Off on VHIO to incorporate Guardant Health’s breakthrough liquid biopsy technology in 2021

A step forward in the validation of reliable preclinical models for cancer research

08/01/2021|Comments Off on A step forward in the validation of reliable preclinical models for cancer research

Seeking out predictive biomarkers for a longer-term response to immunotherapy against NSCLC

31/12/2020|Comments Off on Seeking out predictive biomarkers for a longer-term response to immunotherapy against NSCLC

SEE ALL NEWS

Follow us:

DIRECTION &
PRINCIPAL INVESTIGATORS

Research at VHIO is led by our Director, Josep Tabernero, and supported by a consultative body, VHIO’s Scientific Committee. A total of 26 renowned Principal Investigators manage and run VHIO’s major research themes and programs.

BROWSE OUR PIS

SCIENTIFIC
REPORT
2019

LAUNCH

CLINICAL TRIALS

Driving drug development & targeted therapies against cancer, VHIO has become a leading reference in drug discovery from concept to clinic:

CLINICAL TRIALS OFFICE
RESEARCH UNIT FOR MOLECULAR THERAPY OF CANCER (UITM) – “LA CAIXA” FOUNDATION
CURRENTLY OPEN TRIALS

PROJECTS & INSTITUTIONAL PROGRAMS

Research at VHIO is made possible through the support received from private institutions, funding entities, companies and individuals, as well as International and National Competitive Grants. Find out more about our supporters, current projects and VHIO´s Scientific Coordination Area:

CURRENT PROJECTS
FERO FOUNDATION’S ADVANCED MOLECULAR DIAGNOSTICS PROGRAM
BBVA FOUNDATION’S IMMUNOTHERAPY & IMMUNOLOGY PROGRAM (CAIMI)
“LA CAIXA” INTL RESEARCH & EDUCATION PROGRAM
SCIENTIFIC COORDINATION

EVENTS

VHIO organizes symposia of excellence and ad-hoc courses & workshops through which it shares its expertise and promotes debate and exchange of the highest degree:

VHIO – ”LA CAIXA” SCIENTIFIC SEMINARS SERIES
INTERNATIONAL SYMPOSIA
WORKSHOPS & COURSES
BENCHSTORMING SEMINARS